
TGTX
Healthcare · Biotechnology · $9.75B market cap
$64.51-0.05 (-0.1%)Nov 13, 4:20 PM EST
Next report
Before the open
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -40.8% over 90 days · 30-day revisions 0 up, 2 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 1, 2027 · upcoming | Before the open | 0.60 | — | — |
| Nov 9, 2026 | Before the open | 0.28 | 0.35 | +25.0% |
| Aug 3, 2026 | Before the open | 0.41 | 0.05 | -87.8% |
| May 6, 2026 | Before the open | 0.28 | 0.18 | -35.7% |
| Feb 26, 2026 | Time not confirmed | 0.35 | 0.14 | -60.0% |
| Nov 3, 2025 | Before the open | 0.22 | 0.16 | -27.3% |
| Aug 4, 2025 | Before the open | 0.29 | 0.17 | -41.4% |
| May 5, 2025 | Before the open | 0.17 | 0.03 | -82.4% |
| Feb 26, 2025 | Before the open | 0.09 | 0.15 | +66.7% |
| Nov 4, 2024 | Before the open | 0.03 | 0.02 | -33.3% |
| Aug 6, 2024 | Before the open | -0.04 | 0.04 | +200.0% |
| May 1, 2024 | Before the open | -0.04 | -0.07 | -75.0% |
| Feb 28, 2024 | Before the open | -0.10 | -0.10 |
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome,…
| 0.0% |
| Nov 1, 2023 | Before the open | 0.10 | 0.73 | +630.0% |
| Aug 1, 2023 | Before the open | -0.25 | -0.34 | -36.0% |
| May 1, 2023 | Before the open | -0.34 | -0.28 | +17.6% |
| Feb 28, 2023 | Before the open | -0.26 | -0.39 | -50.0% |
| Nov 10, 2022 | Before the open | -0.38 | -0.26 | +31.6% |
| Aug 8, 2022 | Before the open | -0.57 | -0.30 | +47.4% |
| May 10, 2022 | After the close | -0.59 | -0.51 | +13.6% |
| Mar 1, 2022 | Before the open | -0.68 | -0.70 | -2.9% |
| Nov 4, 2021 | Before the open | -0.57 | -0.65 | -14.0% |
| Aug 2, 2021 | Before the open | -0.50 | -0.59 | -18.0% |
| May 10, 2021 | Before the open | -0.49 | -0.69 | -40.8% |
| Mar 1, 2021 | After the close | -0.61 | -0.72 | -18.0% |
| Nov 9, 2020 | After the close | -0.44 | -0.73 | -65.9% |
| Aug 10, 2020 | Before the open | -0.33 | -0.47 | -42.4% |
| May 11, 2020 | After the close | -0.37 | -0.48 | -29.7% |
| Mar 2, 2020 | After the close | -0.46 | -0.44 | +4.3% |
| Nov 12, 2019 | Before the open | -0.35 | -0.69 | -97.1% |
| Aug 9, 2019 | Before the open | -0.42 | -0.42 | 0.0% |
| May 10, 2019 | Before the open | -0.44 | -0.43 | +2.3% |
| Mar 1, 2019 | After the close | -0.44 | -0.69 | -56.8% |
| Nov 9, 2018 | Before the open | -0.50 | -0.43 | +14.0% |
| Aug 7, 2018 | After the close | -0.50 | -0.59 | -18.0% |
| May 8, 2018 | Before the open | -0.42 | -0.59 | -40.5% |
| Mar 8, 2018 | Before the open | -0.44 | -0.46 | -4.5% |